Despite the biological plausibility and the consistency of the effect of the ACE-I/D polymorphism on ACE activity, associations of the ACE-I/D polymorphism and coronary heart disease, coronary artery restenosis, stroke, and renal disease have been inconsistent [13–16]. Here, ACE is linked to coronary artery disorder.